Literature DB >> 1747667

Oral iron chelation is here.

G J Kontoghiorghes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1747667      PMCID： PMC1671411          DOI： 10.1136/bmj.303.6813.1279

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  L1 (1,2-dimethyl-3-hydroxypyrid-4-one) for oral iron chelation in patients with beta-thalassaemia major.

Authors:  P Töndury; G J Kontoghiorghes; A Ridolfi-Lüthy; A Hirt; A V Hoffbrand; A M Lottenbach; T Sonderegger; H P Wagner
Journal:  Br J Haematol       Date:  1990-12       Impact factor: 6.998

Review 2.  Design, properties, and effective use of the oral chelator L1 and other alpha-ketohydroxypyridines in the treatment of transfusional iron overload in thalassemia.

Authors:  G J Kontoghiorghes
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  Oral iron chelation with L1.

Authors:  M B Agarwal; C Viswanathan; J Ramanathan; D E Massil; S Shah; S S Gupte; D Vasandani; R R Puniyani
Journal:  Lancet       Date:  1990-03-10       Impact factor: 79.321

4.  The law and Lewis Carroll.

Authors:  N A Kurtzman
Journal:  Semin Nephrol       Date:  1986-03       Impact factor: 5.299

5.  Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

Authors:  G J Kontoghiorghes; J G Goddard; A N Bartlett; L Sheppard
Journal:  Clin Pharmacol Ther       Date:  1990-09       Impact factor: 6.875

6.  Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). I. Iron chelation and metabolic studies.

Authors:  G J Kontoghiorghes; A N Bartlett; A V Hoffbrand; J G Goddard; L Sheppard; J Barr; P Nortey
Journal:  Br J Haematol       Date:  1990-10       Impact factor: 6.998

7.  Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). II. Clinical observations.

Authors:  A N Bartlett; A V Hoffbrand; G J Kontoghiorghes
Journal:  Br J Haematol       Date:  1990-10       Impact factor: 6.998

8.  Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.

Authors:  N F Olivieri; G Koren; C Hermann; Y Bentur; D Chung; J Klein; P St Louis; M H Freedman; R A McClelland; D M Templeton
Journal:  Lancet       Date:  1990-11-24       Impact factor: 79.321

9.  Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

Authors:  G J Kontoghiorghes; M A Aldouri; A V Hoffbrand; J Barr; B Wonke; T Kourouclaris; L Sheppard
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-12
  9 in total
  7 in total

1.  Oral iron chelation is here.

Authors:  N T O'Connor
Journal:  BMJ       Date:  1991-12-14

Review 2.  World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.

Authors:  Christina N Kontoghiorghe; Nicholas Andreou; Katerina Constantinou; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-09-26

Review 3.  Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.

Authors:  Annita Kolnagou; Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-12-26

Review 4.  Present status and future prospects of oral iron chelation therapy in thalassaemia and other diseases.

Authors:  G J Kontoghiorghes
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

Review 5.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 6.  The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia.

Authors:  George J Kontoghiorghes; Marios Kleanthous; Christina N Kontoghiorghe
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-01-01       Impact factor: 2.576

Review 7.  New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.

Authors:  George J Kontoghiorghes; Annita Kolnagou; Theodora Demetriou; Marina Neocleous; Christina N Kontoghiorghe
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.